Gong HL et al. |
Effect of formula compatibility on the pharmacokinetics of components from Dachengqi Decoction [See Text] in rats. |
2012 |
Chin J Integr Med |
pmid:22936325
|
Wang JN et al. |
Population pharmacokinetics of naringin in total flavonoids of Drynaria fortunei (Kunze) J. Sm. in Chinese women with primary osteoporosis. |
2012 |
Chin J Integr Med |
pmid:23239001
|
Caccamese S et al. |
Chiral HPLC separation and CD spectra of the C-2 diastereomers of naringin in grapefruit during maturation. |
2003 |
Chirality |
pmid:12923803
|
Jung UJ et al. |
Naringin supplementation lowers plasma lipids and enhances erythrocyte antioxidant enzyme activities in hypercholesterolemic subjects. |
2003 |
Clin Nutr |
pmid:14613759
|
Jeon SM et al. |
Antihypercholesterolemic property of naringin alters plasma and tissue lipids, cholesterol-regulating enzymes, fecal sterol and tissue morphology in rabbits. |
2004 |
Clin Nutr |
pmid:15380892
|
Bailey DG et al. |
Grapefruit juice and drugs. How significant is the interaction? |
1994 |
Clin Pharmacokinet |
pmid:8162660
|
Jeon SM et al. |
Comparison of antioxidant effects of naringin and probucol in cholesterol-fed rabbits. |
2002 |
Clin. Chim. Acta |
pmid:11814474
|
Jagetia GC et al. |
Influence of naringin on ferric iron induced oxidative damage in vitro. |
2004 |
Clin. Chim. Acta |
pmid:15313158
|
Ballard TL et al. |
Naringin does not alter caffeine pharmacokinetics, energy expenditure, or cardiovascular haemodynamics in humans following caffeine consumption. |
2006 |
Clin. Exp. Pharmacol. Physiol. |
pmid:16620293
|
Bailey DG et al. |
Naringin is a major and selective clinical inhibitor of organic anion-transporting polypeptide 1A2 (OATP1A2) in grapefruit juice. |
2007 |
Clin. Pharmacol. Ther. |
pmid:17301733
|
Bailey DG et al. |
Effect of grapefruit juice and naringin on nisoldipine pharmacokinetics. |
1993 |
Clin. Pharmacol. Ther. |
pmid:8275614
|
Bailey DG et al. |
Grapefruit juice--felodipine interaction: mechanism, predictability, and effect of naringin. |
1993 |
Clin. Pharmacol. Ther. |
pmid:8513655
|
Bailey DG et al. |
Grapefruit-felodipine interaction: effect of unprocessed fruit and probable active ingredients. |
2000 |
Clin. Pharmacol. Ther. |
pmid:11103749
|
Bailey DG et al. |
Grapefruit juice-felodipine interaction: effect of naringin and 6',7'-dihydroxybergamottin in humans. |
1998 |
Clin. Pharmacol. Ther. |
pmid:9757148
|
Yamakawa Y et al. |
Pharmacokinetic impact of SLCO1A2 polymorphisms on imatinib disposition in patients with chronic myeloid leukemia. |
2011 |
Clin. Pharmacol. Ther. |
pmid:21633340
|
Luo Z et al. |
Effects of pH on the ability of flavonoids to act as Pickering emulsion stabilizers. |
2012 |
Colloids Surf B Biointerfaces |
pmid:22197223
|
Parmar HS et al. |
DPP-IV inhibitory potential of naringin: an in silico, in vitro and in vivo study. |
2012 |
Diabetes Res. Clin. Pract. |
pmid:22410395
|
Drewnowski A et al. |
Genetic taste markers and food preferences. |
2001 |
Drug Metab. Dispos. |
pmid:11259346
|
Miyazaki N et al. |
Effects of itraconazole, dexamethasone and naringin on the pharmacokinetics of nadolol in rats. |
2013 |
Drug Metab. Pharmacokinet. |
pmid:23419354
|
Shirasaka Y et al. |
Intestinal absorption of HMG-CoA reductase inhibitor pitavastatin mediated by organic anion transporting polypeptide and P-glycoprotein/multidrug resistance 1. |
2011 |
Drug Metab. Pharmacokinet. |
pmid:21206133
|